Pembrolizumab: New Drug for Advanced Lung Cancer UC Davis Health 3:54 8 years ago 10 842 Скачать Далее
Pembrolizumab and the significance of PD-L1 for lung cancer VJOncology 0:56 7 years ago 610 Скачать Далее
Adjuvant pembrolizumab improves RCC disease-free survival | Toni Choueiri Medicine Matters oncology 3:03 3 years ago 1 266 Скачать Далее
Dr. Herbst on Long Term Survival With Pembrolizumab in NSCLC OncLive 1:14 5 years ago 1 481 Скачать Далее
Antibiotics impact outcomes with pembrolizumab in NSCLC patients VJOncology 2:03 3 years ago 261 Скачать Далее
Is pembrolizumab alone sufficient to treat bladder cancer? VJOncology 3:51 7 years ago 1 015 Скачать Далее
KEYNOTE-355: pembrolizumab in triple-negative breast cancer VJOncology 2:07 4 years ago 2 919 Скачать Далее
ESMO 2020 Highlights on pembrolizumab as 1st line therapy for aUC: The KEYNOTE-361 study European Society for Medical Oncology (ESMO) 3:21 3 years ago 2 394 Скачать Далее
Adjuvant Pembrolizumab and Survival in Renal-Cell Carcinoma | NEJM NEJM Group 2:22 4 months ago 1 234 Скачать Далее
How pembrolizumab will change the management of advanced lung cancer VJOncology 0:57 7 years ago 574 Скачать Далее
KEYNOTE-522: 5-year follow-up of pembrolizumab in triple-negative breast cancer VJOncology 4:20 9 months ago 2 789 Скачать Далее
Pembrolizumab is safe and effective and substantially increases overall survival in aNSCLC patients ecancer 5:51 5 years ago 1 733 Скачать Далее
Concurrent pembrolizumab and chemotherapy in classical Hodgkin lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 1:28 2 years ago 179 Скачать Далее
Dr. Brahmer Discusses Frontline Single-Agent Pembrolizumab in Lung Cancer OncLive 1:48 6 years ago 618 Скачать Далее
KEYNOTE-407: pembrolizumab plus chemo improves OS and PFS in NSCLC VJOncology 2:53 3 years ago 384 Скачать Далее